BioNeMo Framework: Path Traversal: '..filename'
CVE-2026-24217 is a high-severity path traversal: '..filename' vulnerability in BioNeMo Framework from NVIDIA, with a CVSS 3.1 base score of 8.8 out of 10. It can be exploited remotely over the network by an unauthenticated attacker, but only if a user takes part, for example by opening a link or file. The record lists version commit dfd83a7 on main as the first without the flaw, so updating BioNeMo Framework to that release or later removes the exposure. There is no confirmed exploitation so far. EPSS estimates a 0.76% chance of exploitation within 30 days, higher than 56% of scored CVEs.
High severity with no evidence of exploitation so far.
What to do
- Update BioNeMo Framework to commit dfd83a7 on main or a later version.
- Read the advisory on nvidia.custhelp.com for workarounds and exact fixed builds.
- Until you can update, restrict network access to the affected service so it is not reachable from untrusted networks.
- Because the attack needs a user to take part, warn users about unexpected links and files related to this product until it is patched.
Affected products and versions
| Vendor | Product | Affected versions | Fixed in |
|---|---|---|---|
| NVIDIA | BioNeMo Framework | before commit dfd83a7 on main | commit dfd83a7 on main |
Version data comes from the organisation that assigned the CVE. Confirm against the vendor advisory before deciding you are unaffected.
How the severity score breaks down
- Attack vector
- NetworkCan be exploited remotely over a network, including the internet.
- Attack complexity
- LowNo special conditions are needed; the attack works reliably.
- Privileges required
- NoneNo account or login is needed.
- User interaction
- RequiredA user must take an action such as opening a file or link.
- Scope
- UnchangedImpact stays within the vulnerable component.
- Confidentiality
- HighAll data handled by the component can be read.
- Integrity
- HighData or code can be modified at will.
- Availability
- HighThe component can be taken down completely.
Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H. Scored by CNA (nvidia.com).
Official description
NVIDIA BioNeMo Core for Linux contains a vulnerability where a user could cause a path traversal by loading a malicious file. A successful exploit of this vulnerability might lead to code execution, denial of service, information disclosure, and data tampering.
Source: the CVE record as published by its numbering authority, via NVD and CVE.org.
The underlying weakness: Path Traversal: '..filename'
The product uses external input to construct a pathname that should be within a restricted directory, but it does not properly neutralize '..filename' (leading backslash dot dot) sequences that can resolve to a location that is outside of that directory.
How developers prevent this class of flaw
- Inputs should be decoded and canonicalized to the application's current internal representation before being validated (CWE-180). Make sure that the application does not decode the same input twice (CWE-174). Such errors could be used to bypass allowlist validation schemes by introducing dangerous inputs after they have been checked.
Timeline
- CVE record published.
- CISA published its SSVC assessment (exploitation: none, automatable: no, technical impact: total).
- Record last changed materially (score, affected products, status or references).
References
Third-party and government advisories
- nvd.nist.gov/vuln/detail/CVE-2026-24217US Government Resource
- cve.org/CVERecord?id=CVE-2026-24217Third Party Advisory
Other vulnerabilities in BioNeMo Framework
- 7.8 High severity
- 8.8 High severity
- 9.8 Critical severity
Recent Path Traversal: '..filename' vulnerabilities
- 7.2 High severity
- 10.0 Critical severity
- 7.5 High severity
- 9.6 Critical severity
- 7.4 High severity
- 7.0 High severity
Spotted an error? Tell us.